The role of intratumoral and systemic IL-6 in breast cancer (Q38093468)

28 August 2017

The role of intratumoral and systemic IL-6 in breast cancer (English)

1 reference

28 August 2017

1 reference

Christine Dethlefsen

1

1 reference

28 August 2017

Grith Højfeldt

series ordinal

2

1 reference

28 August 2017

Pernille Hojman

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

27 March 2013

1 reference

Breast Cancer Research and Treatment

28 August 2017

1 reference

28 August 2017

138

1 reference

28 August 2017

657-664

1 reference

28 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-013-2488-z

28 August 2017

0 references

cites work

The diseasome of physical inactivity--and the role of myokines in muscle--fat cross talk

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Muscles, exercise and obesity: skeletal muscle as a secretory organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

STAT3 can be activated through paracrine signaling in breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Signal transducers and activators of transcription 3 (STAT3) directly regulates cytokine-induced fascin expression and is required for breast cancer cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Oestrogen receptor negative breast cancers exhibit high cytokine content

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Breast cancer stem cells, cytokine networks, and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Common critical pathways in embryogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Epithelial-mesenchymal transitions in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Significance of interleukin-6 (IL-6) in breast cancer (review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Significant impairment in immune recovery after cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Evaluation of leukocyte arylsulphatase a, serum interleukin-6 and urinary heparan sulphate following tamoxifen therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

A systematic review of the association between immunogenomic markers and cancer-related fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Cytokines sing the blues: inflammation and the pathogenesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Cytokines, stress, and depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Influence of age, performance status, cancer activity, and IL-6 on anxiety and depression in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Inflammatory marker changes in a yearlong randomized exercise intervention trial among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Exercise training and cytokines in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Exercise and lymphocyte activation following chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Dose effects of relaxation practice on immune responses in women newly diagnosed with breast cancer: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

Post-cancer fatigue is not associated with immune activation or altered cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2488-Z

10.1007/S10549-013-2488-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference